Skip to main content
. Author manuscript; available in PMC: 2012 Jun 15.
Published in final edited form as: Vaccine. 2011 May 1;29(27):4499–4506. doi: 10.1016/j.vaccine.2011.04.038

Figure 3.

Figure 3

Figure 3

Kinetics of the median percentage of serotype-specific IgG that is avid for selected non-PCV serotypes in those that did or did not receive the 12 month 23vPPS